Pfizer seeks approval for omicron booster in kids over 5 years old

Pfizer is seeking approval from the FDA for its updated COVID-19 booster shot targeting the omicron variant in kids between the ages of 5 and 11.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.